Bonnie I. Scott, an Associate in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was featured in the article “Why 3D Printing Has ‘Tremendous Potential’ for Big Pharma,” a Q&A with KQED Public Television reporter, Christina Farr.
Following is an excerpt:
Do you anticipate that people will start printing their own drugs and medical devices?
I think it’s possible, but it’s far off. The kind of trajectory it may follow is to start with the traditional manufacturing environment, then move into the pharmacy space — the pharmacist would have a 3-D printer to combine pills, for instance — and once the kinks are worked out it might be used at home. Of course, there would still need to be some kind of screening process and buy-in from the doctor, pharmacist and patient to make sure everyone is on the same page.
Ms. Scott also writes on this topic at Pharma MedTech Insights, an Epstein Becker Green blog.
